Literature DB >> 27994691

Giant Cell Tumor with Secondary Aneurysmal Bone Cyst Shows Heterogeneous Metabolic Pattern on 18F-FDG PET/CT: A Case Report.

Hee Jeong Park1, Seong Young Kwon1, Sang-Geon Cho2, Jahae Kim2, Ho-Chun Song2, Sung Sun Kim3, Yeon Hong Yoon4, Jin Gyoon Park5.   

Abstract

Giant cell tumor (GCT) is a generally benign bone tumor accounting for approximately 5 % of all primary bone neoplasms. Cystic components in GCTs that indicate secondary aneurysmal bone cysts (ABCs) are reported in 14 % of GCTs. Although both of them have been described separately in previous reports that may show considerable fluorodeoxyglucose (FDG) uptake despite their benign nature, the findings of GCT with secondary ABC on 18F-FDG positron emission tomography/computed tomography (PET/CT) have not been well-known. We report a case of GCT with secondary ABC in a 26-year-old woman. 18F-FDG PET/CT revealed a heterogeneous hypermetabolic lesion in the left proximal femur with the maximum standardized uptake value of 4.7. The solid components of the tumor showed higher FDG uptake than the cystic components. These observations suggest that the ABC components in GCTs show heterogeneous metabolic patterns on 18F-FDG PET/CT.

Entities:  

Keywords:  18F-FDG; Aneurysmal bone cyst; Giant cell tumor; PET/CT

Year:  2016        PMID: 27994691      PMCID: PMC5135695          DOI: 10.1007/s13139-016-0423-z

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  17 in total

1.  (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma.

Authors:  A L Folpe; R H Lyles; J T Sprouse; E U Conrad; J F Eary
Journal:  Clin Cancer Res       Date:  2000-04       Impact factor: 12.531

2.  Fluorine-18-fluorodeoxyglucose assessment of glucose metabolism in bone tumors.

Authors:  A C Kole; O E Nieweg; H J Hoekstra; J R van Horn; H S Koops; W Vaalburg
Journal:  J Nucl Med       Date:  1998-05       Impact factor: 10.057

3.  Radionuclide bone scanning in giant cell tumor.

Authors:  D Van Nostrand; J E Madewell; L M McNiesh; R W Kyle; D Sweet
Journal:  J Nucl Med       Date:  1986-03       Impact factor: 10.057

4.  FDG accumulation in tumor tissue.

Authors:  K Kubota; R Kubota; S Yamada
Journal:  J Nucl Med       Date:  1993-03       Impact factor: 10.057

5.  Overexpression of hexokinase-2 in giant cell tumor of bone is associated with false positive in bone tumor on FDG-PET/CT.

Authors:  Manabu Hoshi; Jun Takada; Naoto Oebisu; Kanako Hata; Makoto Ieguchi; Hiroaki Nakamura
Journal:  Arch Orthop Trauma Surg       Date:  2012-07-24       Impact factor: 3.067

6.  FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions.

Authors:  J Aoki; H Watanabe; T Shinozaki; K Takagishi; H Ishijima; N Oya; N Sato; T Inoue; K Endo
Journal:  Radiology       Date:  2001-06       Impact factor: 11.105

7.  Grading of tumors and tumorlike lesions of bone: evaluation by FDG PET.

Authors:  M Schulte; D Brecht-Krauss; B Heymer; A Guhlmann; E Hartwig; M R Sarkar; C G Diederichs; A Von Baer; J Kotzerke; S N Reske
Journal:  J Nucl Med       Date:  2000-10       Impact factor: 10.057

8.  Giant cell tumor along with secondary aneurysmal bone cyst of scapula: A rare presentation.

Authors:  Rana K Sherwani; Sufian Zaheer; Amir B Sabir; Siddharth Goel
Journal:  Int J Shoulder Surg       Date:  2008-07

9.  Giant-cell tumor of bone.

Authors:  M Campanacci; N Baldini; S Boriani; A Sudanese
Journal:  J Bone Joint Surg Am       Date:  1987-01       Impact factor: 5.284

Review 10.  FDG-PET for evaluating musculoskeletal tumors: a review.

Authors:  Jun Aoki; Keigo Endo; Hideomi Watanabe; Tetsuya Shinozaki; Takashi Yanagawa; Adel Refaat Ahmed; Kenji Takagishi
Journal:  J Orthop Sci       Date:  2003       Impact factor: 1.601

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.